These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1578557)

  • 1. Autogenous saphenous vein versus PTFE bypass for above-knee femoropopliteal reconstruction.
    Whittemore AD
    J Vasc Surg; 1992 May; 15(5):895-7. PubMed ID: 1578557
    [No Abstract]   [Full Text] [Related]  

  • 2. Above-knee femoropopliteal reconstruction with polytetrafluoroethylene: a good alternative to saphenous vein bypass.
    Laurendeau F; Lassonde J
    Can J Surg; 1989 Jan; 32(1):48-50. PubMed ID: 2910380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Femoropopliteal bypass for claudication: vein vs. PTFE.
    Allen BT; Reilly JM; Rubin BG; Thompson RW; Anderson CB; Flye MW; Sicard GA
    Ann Vasc Surg; 1996 Mar; 10(2):178-85. PubMed ID: 8733871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee.
    Woratyla SP; Darling RC; Chang BB; Paty PS; Kreienberg PB; Leather RP; Shah DM
    Am J Surg; 1997 Aug; 174(2):169-72. PubMed ID: 9293837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts.
    Sala F; Hassen-Khodja R; Lecis A; Bouillanne PJ; Declemy S; Batt M
    Ann Vasc Surg; 2003 Jul; 17(4):401-7. PubMed ID: 14670018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified?
    Quiñones-Baldrich WJ; Busuttil RW; Baker JD; Vescera CL; Ahn SS; Machleder HI; Moore WS
    J Vasc Surg; 1988 Sep; 8(3):219-28. PubMed ID: 3418827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regarding "Stent grafts vs femoropopliteal bypass".
    Takagi H; Tanabashi T; Kawai N; Umemoto T
    J Vasc Surg; 2007 Aug; 46(2):399. PubMed ID: 17664120
    [No Abstract]   [Full Text] [Related]  

  • 8. Graft type for femoro-popliteal bypass surgery.
    Mamode N; Scott RN
    Cochrane Database Syst Rev; 2000; (2):CD001487. PubMed ID: 10796649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saphenous vein or PTFE for femoropopliteal bypass. A prospective randomized trial.
    Tilanus HW; Obertop H; Van Urk H
    Ann Surg; 1985 Dec; 202(6):780-2. PubMed ID: 3907550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft type for femoro-popliteal bypass surgery.
    Twine CP; McLain AD
    Cochrane Database Syst Rev; 2010 May; (5):CD001487. PubMed ID: 20464717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?
    Sterpetti AV; Schultz RD; Feldhaus RJ; Peetz DJ
    J Vasc Surg; 1985 Nov; 2(6):907-12. PubMed ID: 3877178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene.
    Archie JP
    Ann Vasc Surg; 1994 Sep; 8(5):475-84. PubMed ID: 7811585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: Polytetrafluoroethylene graft versus reversed saphenous vein.
    Ballotta E; Renon L; Toffano M; Da Giau G
    J Vasc Surg; 2003 Nov; 38(5):1051-5. PubMed ID: 14603216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial.
    Klinkert P; Schepers A; Burger DH; van Bockel JH; Breslau PJ
    J Vasc Surg; 2003 Jan; 37(1):149-55. PubMed ID: 12514593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing vein with collagen impregnated woven polyester prosthesis in above-knee femoropopliteal bypass grafting.
    Tofigh AM; Warnier De Wailly G; Rhissassi B
    Int J Surg; 2007 Apr; 5(2):109-13. PubMed ID: 17448975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An argument against all-autogenous tissue for vascular bypasses below the inguinal ligament.
    Moore WS; Quiñones-Baldrich WJ
    Adv Surg; 1991; 24():91-101. PubMed ID: 1996531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting.
    Takagi H; Goto SN; Matsui M; Manabe H; Umemoto T
    J Vasc Surg; 2010 Jul; 52(1):232-6. PubMed ID: 20471778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Above-knee polytetrafluoroethylene femoropopliteal bypass graft: Is it a reasonable alternative to the below-knee reversed autogenous vein graft?
    O'Donnell TF; Farber SP; Richmand DM; Deterling RA; Callow AD
    Surgery; 1983 Jul; 94(1):26-31. PubMed ID: 6857508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polytetrafluoroethylene use for above-knee femoropopliteal bypass in critical limb ischemia.
    El-Kayali AA
    Saudi Med J; 2003 Jun; 24(6):669-71. PubMed ID: 12847601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoropopliteal bypass: saphenous vein and expanded polytetrafluoroethylene grafts.
    Wooster DL; Provan JL; Sojka SG; Madras PN
    Can J Surg; 1982 Nov; 25(6):666-9. PubMed ID: 7139424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.